C EDGE HEAD 2 HEAD Efficacy and safety of elbasvir grazoprevir versus sofosbuvir pegylated interferon ribavirin PR in treatment naive and prior PR treatment failure subject with chronic HCV GT1 or 4 infection

---

Husa P., Jan s., Urbanek P., Gerstoft J., Weis n., Horvath g., ...Daha Fazla

EASL, 13 - 17 Nisan 2016, (Tam Metin Bildiri)

• Yayın Türü: Bildiri / Tam Metin Bildiri
• Erciyes Üniversitesi Adresli: Evet